Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,680 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.
Stella S, Zammit V, Vitale SR, Pennisi MS, Massimino M, Tirrò E, Forte S, Spitaleri A, Antolino A, Siracusa S, Accurso V, Mannina D, Impera S, Musolino C, Russo S, Malato A, Mineo G, Musso M, Porretto F, Martino B, Di Raimondo F, Manzella L, Vigneri P, Stagno F. Stella S, et al. Among authors: russo s. Int J Mol Sci. 2019 May 6;20(9):2226. doi: 10.3390/ijms20092226. Int J Mol Sci. 2019. PMID: 31064152 Free PMC article.
Epigenetic therapy in myelodysplastic syndromes.
Musolino C, Sant'antonio E, Penna G, Alonci A, Russo S, Granata A, Allegra A. Musolino C, et al. Among authors: russo s. Eur J Haematol. 2010 Jun;84(6):463-73. doi: 10.1111/j.1600-0609.2010.01433.x. Epub 2010 Feb 23. Eur J Haematol. 2010. PMID: 20192987 Review.
Cardiac involvement in patients with hematologic malignancies.
Allegra A, Alonci A, Russo S, Cannavò A, Penna G, D'Angelo A, Bellomo G, Musolino C. Allegra A, et al. Among authors: russo s. J Investig Med. 2010 Oct;58(7):859-74. doi: 10.231/JIM.0b013e3181efbc4e. J Investig Med. 2010. PMID: 20683345 Review.
Nanoparticles in oncology: the new theragnostic molecules.
Allegra A, Penna G, Alonci A, Rizzo V, Russo S, Musolino C. Allegra A, et al. Among authors: russo s. Anticancer Agents Med Chem. 2011 Sep;11(7):669-86. doi: 10.2174/187152011796817682. Anticancer Agents Med Chem. 2011. PMID: 21787275 Review.
Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remission.
Alonci A, Allegra A, Russo S, Penna G, Bellomo G, D'Angelo A, Campo S, Cannavò A, Centorrino R, Musolino C. Alonci A, et al. Among authors: russo s. Acta Haematol. 2012;127(1):1-6. doi: 10.1159/000330948. Epub 2011 Oct 4. Acta Haematol. 2012. PMID: 21986252 Clinical Trial.
1,680 results